drugset / Trial / NCT03371888

The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders

NCT03371888

Phase 2/3 Completed 58 enrolled Medical University of Silesia
RandomizedParallel-groupDouble-blindTreatment

Summary

The Platelet-Rich Plasma intramuscular injections into the masseter and temporalis muscle were performed to reduce painful temporomandibular disorder symptoms,such as myalgia, myofascial pain and myofascial pain with referrals. Patients(n=120) were randomly divided into two groups: experimental(n=60) and control group(n=60). In controls injections with 0,9% NaCl were performed. Pain intensity was measured with NPRS (numeriic pain rating scale, 0= no pain, 11= the worst pain that one can imagine) before(0 day), during(10 day) and after(20 day) the therapy with PRP injections.

Timeline

Start
2017-12-07
Primary completion
2018-12-15
Completion
2019-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 0.5 ml Intramuscular